Drugs@FDA document

VELCADE Pediatric Amendment 1 · NDA 021602 SUPPL-42

Drugs@FDA document · TAKEDA PHARMS USA · Jan 26, 2011

Key facts

Drug name VELCADE
Document type Pediatric Amendment 1
Application NDA021602
Submission SUPPL-42
Company TAKEDA PHARMS USA
Document date Jan 26, 2011
FDA document accessdata.fda.gov

At a glance

  • Efficacy-Pediatric Document categories
  • 10–99 Documents for this application
  • None USP chapters cited in this application's documents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA documents

Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date:

Browse all Drugs@FDA documents